PMAPX
Price
$22.77
Change
+$0.09 (+0.40%)
Updated
Jan 17 closing price
Net Assets
1.32B
VIMSX
Price
$74.75
Change
+$0.37 (+0.50%)
Updated
Jan 17 closing price
Net Assets
176.87B
Ad is loading...

PMAPX vs VIMSX

Header iconPMAPX vs VIMSX Comparison
Open Charts PMAPX vs VIMSXBanner chart's image
Principal MidCap S&P 400 Index R6
Price$22.77
Change+$0.09 (+0.40%)
VolumeN/A
Net Assets1.32B
Vanguard Mid Cap Index Investor
Price$74.75
Change+$0.37 (+0.50%)
VolumeN/A
Net Assets176.87B
PMAPX vs VIMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PMAPX vs. VIMSX commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAPX is a StrongBuy and VIMSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 177B vs. PMAPX (1.32B). VIMSX pays higher dividends than PMAPX: VIMSX (1.38) vs PMAPX (1.24). PMAPX was incepted earlier than VIMSX: PMAPX (8 years) vs VIMSX (27 years). PMAPX is a more actively managed with annual turnover of: 20.40 vs. VIMSX (13.00). PMAPX has a lower initial minimum investment than VIMSX: PMAPX (0) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 20.82 vs. PMAPX (8.01). VIMSX return over 5 years is better than : 49.84 vs. PMAPX (16.76).
PMAPXVIMSXPMAPX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years27 years-
Gain YTD3.4203.205107%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.32B177B1%
Annual Yield % from dividends1.241.3890%
Returns for 1 year8.0120.8238%
Returns for 3 years-2.0712.31-17%
Returns for 5 years16.7649.8434%
Returns for 10 yearsN/A128.77-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAMI25.150.59
+2.40%
Acadian Asset Management Inc
RYTM54.661.00
+1.86%
Rhythm Pharmaceuticals
LH238.771.47
+0.62%
Laboratory Corp
GLYC0.25N/A
-0.55%
GlycoMimetics
VERI2.70-0.16
-5.59%
Veritone